Could a new diagnostic technology save your life? For 50% of people who have coronary artery disease, the first symptom they ever have is a heart attack. About 10-20% of those people die. Waiting for symptoms to occur is obviously a bad strategy. Unfortunately, the majority of diagnostic tests available today are either insensitive to early disease or are highly invasive. A new test called a malfunction cardiogram (MCG) is a new noninvasive way of finding very early evidence of heart disease. By finding heart disease long before it is symptomatic, we are able to intervene with diet, lifestyle and other treatments as necessary to prevent its progression or even reverse the heart disease. The MCG is actually quite comparable to the gold standard test for heart disease called an angiogram. The difference is the angiogram is a highly invasive test whereas the MCG is completely noninvasive. The MCG outperforms other cardiac tests such as: a stress test, a stress echocardiogram, a nuclear medicine stress test, a resting 12-lead EKG, a blood test called tropponin, MRI angiogram, and CT angiogram for all phases of coronary artery disease. Your coronary arteries have great redunancy built into them. Most people will not be symptomatic until your coronary arteries are blocked by as much as 70%; and at that time, you are at great risk for rupture of that blockage resulting in a heart attack. The MCG will discover a blockage as small as 40-50% in the vast majority of patients (80-90%). This allows us to start your diet, lifestyle and other interventions long before symptoms and the risk of a heart attack. The MCG is so sensitive that we are able to use it to evaluate the effectiveness of treatments. If your MCG suggests a level of coronary artery disease, we will place you on appropriate interventioins. We would then follow your MCG to be sure that your test scores are improving. if your test scores are not improving, it would give us the opportunity to intervene more aggressively.